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Primary malignant tumours of the small intestine (TSI) are defined as
tumours that originate from the duodenum, jejunum, ileum or
Meckel’s diverticulum. According to the ninth revision of the
International Classification of Diseases (1977), TSI are coded as 152.
The rarity of TSI is an important reason for the comparatively
late interest in the epidemiologic features of these tumours. To our
knowledge, the first epidemiological analysis based on population-
based data was published in 1968 (Brookes et al, 1968).
Population-based analyses of the epidemiology of TSI have not
been published until now in the Federal Republic of Germany
(FRG). At present, the Federal Republic of Germany does not have
cancer registries that cover the complete geographic territory. Out
of the existing cancer registries, the Saarland Cancer Registry and
the National Cancer Registry of the German Democratic Republic
(GDR) (until 1989) are the only registries with a data quality, i.e.
completeness that is comparable with international cancer
registries (Parkin et al, 1997). Therefore, the epidemiological
features of malignant tumours can only be analysed by regionally
limited population-based cancer registries within the FRG.
The aim of this study is to present the epidemiological charac-
teristics of TSI in the FRG based on cancer registry data of the
GDR and the federal state Saarland. Results are compared with
international epidemiological findings.
MATERIALS AND METHODS
We analysed data from the Saarland Cancer Registry (Statistisches
Landesamt Saarbrücken, 1996) for the period 1982–1993 and from
the GDR for the period 1976–1989. Incidence rates were standard-
ized by using the world population as the standard (WSR) (Parkin
et al, 1997). We calculated truncated incidence rates (age 0–74
years) because the registration of cancer in the elderly (i.e. 75
years and more) in the former GDR probably was incomplete due
to underreporting.
Malignant lymphomas of the small intestine that are assigned to
the International Classification of Diseases (ICD)-9 codes 200 or
202 ‘Malignant neoplasms of lymphatic and haematopoetic tissue’
were included in the incidence rates. Primary extranodal malignant
lymphoma of the small intestine coded with 200 or 202 were iden-
tified by comparing topography codes of the International
Classification of Diseases for Oncology (ICD-O; Percy et al,
1990) with the corresponding ICD-O morphology codes. We only
included TSI with behaviour that was coded as primary malignant
(fifth digit of morphology code = 3). Only carcinoids were also
included with behaviour code ‘1’ (i.e. neoplasm of uncertain
behaviour) because these tumours are also considered as malig-
nant (except those of the appendix).
We analysed the topographical distribution of TSI only for the
GDR because the information about the topography of TSI was
determined in only 45% of the cases of the federal state of
Saarland. We do not present the sex-specific histologic distribution
of TSI from Saarland because the precision of these estimates for
the Saarland Cancer Registry was too low.
Analyses of the histological distribution of the tumours were
based on the ICD-O (Percy et al, 1990). Histologies coded
according to the first edition of ICD-O (WHO, 1976) were trans-
ferred to codes of the second edition of ICD-O. We used a
median/average smoothing process to dampen the roughness of the
age-specific incidence rates for the four histopathological
subgroups of the GDR so that any underlying pattern is more
clearly seen (Selvin, 1996). We compared our results with data
from other cancer registries published by the International Agency
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for Research on Cancer (IARC), which presents incidence data of
cancer registries of the whole world in a standardized way (Parkin
et al, 1992, 1997). We combined data for the registration periods
1983–1987 (Parkin et al, 1992) and 1988–1992 (Parkin et al, 1997)
to facilitate the comparison with our findings and to get more
stable incidence rates.
RESULTS
Between 1976 and 1989, 1046 persons under 75 years of age of the
GDR (about 17 million residents) were diagnosed with TSI.
Morphologically confirmed cases reported to the registry were
coded according to the ICD-O (1046 cases) with the exception of
the calendar year 1985 (97 cases). Ninety-seven per cent of the
cases (cases from 1985 excluded) were morphologically
confirmed. The overall incidence rate for the registration periods
was 4.6 per million males and 3.3 per million females per year.
In the federal state Saarland 101 cases under age of 75 years
with TSI were reported to the cancer registry between 1982 and
1993. About 98% of these cases were morphologically confirmed.
The overall incidence rate for the registration periods was 6.2 per
million males and 4.6 per million females per year. The overall
incidence rates of the federal state Saarland for men were about
1.35 times, and for women about 1.40 times, the rate of the GDR.
After the age of 30 years, the incidence of TSI increased with
increasing age. Men had a higher risk of TSI then women
(Saarland: 35%, GDR: 40% respectively), after adjusting for age
(Table 1).
For neither cancer registry was there evidence of an increase or
decrease in the incidence rates of the overall group of TSI or
histopathological subgroup over time (data not shown). Table 2
presents the incidence rates of the histopathological subgroups of
TSI. We found the highest risk for carcinomas and malignant
carcinoids in both registries. The risk is about 45% and 35% lower
for carcinomas and malignant carcinoids in the former GDR, after
adjusting for age. The risk for lymphomas in the former GDR
is about twice as high as compared to Saarland, after adjusting
for age.
Table 1 Sex-specific incidence rates of primary malignancies of the small intestine in the GDR (1046 cases) and the federal state Saarland (101 cases)
Registry Period Population Sex Incidence ratea Cases (n)b Male : Female ratio
in millions
(residents)
Saarland 1982–1993 1 Males 6.2 51 1.35
Females 4.6 50
GDR 1976–1989 17 Males 4.6 514 1.40
Females 3.3 532
aPer 1 000 000 subjects per year; age-standardized (WSR), truncated 0–74 years; bGDR: calendar year 1985 is excluded from the calculation of the incidence
rates.
Table 2 Incidence rates (WSR) of the histopathological subgroups of primary malignant tumours of the small intestine
Registry Sex Carcinomas Malignant carcinoids Sarcomas Malignant lymphomas
NI R NI R NI R N I R
Saarland (1982–1993) M + F 43 2.2 32 1.7 12 0.7 6 0.3
GDR (1976–1989)a M + F 350 1.2 312 1.1 172 0.7 159 0.6
M 164 1.4 165 1.5 80 0.7 86 0.8
F 186 1.1 147 0.9 92 0.6 73 0.5
M: males, F: females; n: number of cases, IR: age-truncated (0–74 years) and age-standardized incidence rates (world standard); cases per million. aGDR:
calendar year 1985 is excluded from the calculation of the incidence rates.
Table 3 Topographical and histological distribution of 1046 morphologically confirmed primary malignant tumours of the small intestine in the GDR
(1976–1989)a
Duodenum Duodenojejunal Jejunum Ileum Not otherwise Overall
flexura specified
Carcinoma 0.37 0.08 0.34 0.20 0.23 1.22
Malignant carcinoid 0.17 0.11 0.11 0.46 0.25 1.10
Sarcoma 0.06 0.02 0.18 0.21 0.19 0.65
Malignant lymphoma 0.03 0.02 0.11 0.23 0.24 0.62
Others 0.01 0.00 0.00 0.01 0.01 0.03
Overall 0.64 0.23 0.74 1.11 0.92
aAge-standardized incidence rates (WSR), truncated 0–74 years; cases per million; calendar year 1985 is excluded from the calculation of the incidence rates;
all incidence rates less than 0.005 were rounded down.1442 A Stang et al
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Figure 1 Age-specific incidence rates for primary malignant tumours of the small intestine for males (A) and females (B) (cases per million), GDR 1976–1989
(1985 excluded)
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Figure 2 Incidence rates for primary malignant tumours of the small intestine (malignant lymphoma excluded) in European Cancer Registries 1983–1992
(Parkin et al, 1992, 1997). Age-standardized incidence rates (WSR), truncated 0–74 years; cases per million (calendar year 1985 is excluded from the
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Within the histopathologic subgroups, certain histologies are
predominating. Leiomyosarcomas (63%) are the most frequent
sarcomas followed by malignant schwannomas (7%). Adeno-
carcinomas (93%) are the most frequent carcinomas and non-
Hodgkin’s lymphomas (84%) are the most frequent malignant
lymphomas.
Figure 1 presents age-specific incidence rates for all TSI and the
four histopathological subgroups. The rates were quite low until
the age of 30 years for all types, after which they rose sharply. For
carcinomas, malignant lymphomas and sarcomas, the incidence
rates continued to increase with each increasing 5-year age group,
whereas that for carcinoids levelled off after the age of 54 years.
The sex-specific comparison of age-specific incidence rates of
the histological subgroups from the former GDR shows that the
higher carcinoma risk of males is mainly due to higher age-
specific incidence rates between 40 and 64 years at age. The
higher risk of carcinoids in males is mainly due to higher age-
specific incidence rates between 55 and 74 years at age. Age-
specific incidence rates for malignant lymphoma are continuously
higher for males than for women. These differences are accentu-
ated in the younger (0–10 years) and older age groups (70–74
years).
Table 3 presents the incidence rates for the four histopatholog-
ical subgroups of TSI stratified by the origin of the tumours within
the small intestine. The overall incidence of TSI continuously
increases from the proximal part (duodenum) to the distal part of
the small intestine (ileum). The histological subtypes show distinct
topographical patterns within the small intestine: the incidence of
carcinomas is highest in the duodenum; carcinoids and malignant
lymphomas predominantly occur in the ileum.
The worldwide comparison shows that incidence rates tend to
be lower in former communist block and Asian countries. Nations
with western civilization (Western Europe and North America)
tend to have the highest incidence rates. Within Western Europe,
the incidence rates of the federal state of Saarland are represented
in the middle range. Also, within the former communist block
countries, incidence rates of the GDR are represented in the
middle range (Figure 2).
DISCUSSION
Compared to analyses of the USA (Weiss, 1987), we found that the
risk for carcinoids in males is about 60% larger than in females.
This risk difference is accentuated for the age range 55–74 years.
The overall incidence rates of the German cancer registries were
considerably lower than the rates from the USA, especially for
men. In contrast to the USA, we did not find relevant increases of
the incidence rates of all tumours of the small intestine combined
or the histological subgroups for either sex over time. Analyses of
cancer registry data from Canadian provincial registries by Gabos
et al (1993) showed a small increasing trend for malignant
lymphomas in both genders, although the incidence estimates
were based on small numbers in comparison to the number of
lymphoma cases in the GDR.
Several factors indicate that the aetiology within the group
of TSI is heterogenous. Carcinomas, carcinoids, malignant
lymphomas and sarcomas derive from different tissues and cell
lines respectively. The majority of tumours of TSI that manifest
before the age of 35 years are malignant lymphomas, whereas carci-
noma and carcinoids prevail in the age group of 35 years and above.
The histological subtypes of TSI show distinct topographical
distributions within the small intestine. Predisposing diseases result
in specific histological subtypes of TSI, e.g. malabsorptive diseases
of the small intestine (gluten-sensitive enteropathy, idiopathic steat-
orrhoea and a-chain disease) and malignant lymphomas (Ellis,
1987), Crohn’s disease and adenocarcinomas (Lightdale et al, 1975;
Hoffman et al, 1977; Richards et al, 1989), familial polyposis
syndromes and adenocarcinomas (Jagelman et al, 1988; Spigelman
et al, 1989a, 1989b), immunosuppression or organ transplantation
and malignant lymphomas (Penn, 1987).
Furthermore, dietary factors may increase the risk of TSI. In a
correlational study, Lowenfels et al found that the amount of daily
animal protein and animal fat consumption is positively associated
with the risk of TSI (Lowenfels and Sonni, 1977). A recent case-
control study by Chow et al (1993) showed that the frequent
consumption of red meat or salt-cured/smoked foods is associated
with two-to threefold increases of the risk of TSI. The ecological
comparison of the meat consumption in the former GDR and the
FRG until 1989 does not show a relevant difference in the per
capita meat consumption per year (Bundesministerium für
Landwirtschaft, 1980, 1997).
There are several factors of the study that may have affected our
results. First, although the completeness of the analysed data sets
of the two German cancer registries is about 90–95% (Parkin et al,
1997), the registration methods of the registries are not identical.
For example, 40–50% of all new reports of cancer cases to the
Saarland Cancer Registry come from pathologists only, whereas
the majority of case reports to the registry of the GDR came from
clinicians and pathologists. This difference might explain the
lower incidence of malignant lymphoma of the small intestine in
the federal state of Saarland because without additional clinical
information, the reviewing pathologist cannot clearly decide
whether a malignant lymphoma within the small intestine is a
primary extranodal malignant lymphoma of the small intestine or a
primary systemic malignant lymphoma with secondary involve-
ment of the small intestine. The autopsy proportion in the GDR
was substantially higher (25%) compared to West Germany (8%)
(Becker, 1998). Although the higher proportion of autopsies in the
GDR should result in higher incidence rates of TSI due to the
discovery of asymptomatic TSI, the incidence rates of TSI in the
GDR are lower than in the federal state of Saarland.
Second, within the periampullar region, adenocarcinomas can
be misclassified as adenocarcinomas of the ductus of the bile
(including the papilla of Vater), of the duodenum and of the
pancreas (Jones et al, 1985). It is still unclear how much this
potential misclassification contributes to the high proportion of
carcinomas in the duodenum, which presents only about 4% of the
length of the small intestine (Weiss, 1987). Also, tumours of the
ileocaecum might be misclassified as colon or ileal tumours.
Third, malignant lymphomas may involve the small intestine
primarily as extranodal malignant lymphomas with limited
or regional lymph node involvement, or in connection with dissemi-
nated disease. It is often difficult to distinguish between primary and
secondary involvement of the small intestine. The distinction
becomes even more difficult when the tumour stage is advanced or
when multiple sites within the gastrointestinal tract are involved
(Ashley, 1988). Therefore, incidence estimates of malignant
lymphomas of the small intestine must be evaluated cautiously.
Fourth, depending on the histopathological subgroup, 12–29%
of cases with TSI are asymptomatic and discovered only coinci-
dentally (Weiss, 1987; Matsuo et al, 1994). This finding indicates
that we probably underestimate the incidence rate of TSI.1444 A Stang et al
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